Apricus Biosciences reports Takeda, its partner in the UK, accepts first shipment of Vitaros for ED
Orphan cancer specialists Bioalliance Pharma, Topotarget merge in all-stock deal
Repligen Corporation set to join the S&P SmallCap 600
Visit our sites for b2b sales and banking employees:
cafeb2bsales.com
cafebanking.com
Submit an article to cafepharma's CP Wire. Click here to find out more.
| Company | Average | Last 24h |
Increase |
|---|---|---|---|
| Zogenix | 2 | 13 | 550 % |
| Vascular Insights | 1 | 6 | 500 % |
| Isis Pharmaceuticals | 11 | 48 | 336 % |
| CGI Pharma | 1 | 4 | 300 % |
| Syneron Medical | 1 | 4 | 300 % |
| Ventana Medical Systems | 11 | 42 | 282 % |
| Ascent Healthcare Solutions | 3 | 11 | 267 % |
| Janssen Biotech | 6 | 22 | 267 % |
| Teva Pharmaceuticals | 15 | 53 | 253 % |
| Vertex Pharmaceuticals | 14 | 49 | 250 % |
| Company | Average | Last 24 hrs |
Increase |
|---|---|---|---|
| CASMED | 1 | 13 | 1200 % |
| Alphatec Spine | 1 | 12 | 1100 % |
| Apricus Biosciences | 1 | 12 | 1100 % |
| Emergent BioSolutions | 4 | 41 | 925 % |
| Cleveland BioLabs | 4 | 35 | 775 % |
| AxoGen | 1 | 8 | 700 % |
| Agenus | 6 | 43 | 617 % |
| Dehaier Medical Systems | 1 | 7 | 600 % |
| Cantel Medical | 2 | 14 | 600 % |
| BioAlliance | 16 | 100 | 525 % |